【浙商医药|孙建】微创机器人24A:海外爆发,收入高增可期

杏林建研
13 Apr

分析师:吴天昊(S1230523120004)司清蕊(S1230523080006)来源:浙商证券医药研究团队具体参见2025年4月11日报告《海外爆发,收入高增可期——微创机器人2024年报点评报告》,如需报告全文或数据底稿,请联系团队成员或对口销售。投资要点公司披露年报,2024年实现收入2.57亿元,其中国内图迈腔镜机器人累计装机突破30台,省级头部三甲医院及全国百强医院占比提升至60%以上...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10